ROCHE - SARS-CoV-2 Rapid Antigen- 25 Tests
Device ID for issuing Green Pass: 1604
The SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunoassay used for the qualitative detection of SARS-CoV-2 virus specific antigens present in the human nasopharynx. The test is intended for use for the detection of SARS-CoV-2 virus antigen in subjects with suspected infection. This product is intended for professional use only in laboratory or Point of Care (POC) environments.
The new ROCHE SARS-CoV-2 Rapid Antigen Test is used for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab samples.
Registration Ministry of Health: 2008838
The Roche Rapid Buffer for SARS-CoV-2 is a rapid chromatographic immunoassay used for the qualitative detection of SARS-CoV-2 virus-specific antigens present in the human nasopharynx. The test is intended to be used for the detection of virus antigen in individuals with suspected infection. This product is intended for use by healthcare professionals only. It requires no instrumentation. It allows for the qualitative detection of the SARS-CoV-2 virus nucleocapsid protein present in the human nasopharyngeal tract. It can be used to assess whether a person is infected with SARS-CoV-2 by providing a qualitative result showing colored bands when the SARS-CoV-2 antigen is detected.
interpretation of results
- A colored line appears at the top of the results window to indicate that the test is working correctly. This is the control line (C). Even if the control line is blurred, the test should be considered correct. If the control line is not visible, the test is invalid.
- If the result is positive, a colored line will appear at the bottom of the result window. This is the test line (T). Even if the test line is very weak or uneven, the test result should be interpreted as positive.